Paion AG Top Insiders
| PAIOFDelisted Stock | USD 0.02 0.00 0.00% |
Paion AG employs about 62 people. The company is managed by 5 executives with a total tenure of roughly 145 years, averaging almost 29.0 years of service per executive, having 12.4 employees per reported executive. Examination of Paion AG's management performance can provide insight into the company performance.
| Ralf Penner Director Director of Investor Relations and PR |
| Thomas Stoehr Insider VP Devel |
Paion |
Paion AG Management Team Effectiveness
The company has return on total asset (ROA) of (0.033) % which means that it has lost $0.033 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.0965) %, meaning that it generated substantial loss on money invested by shareholders. Paion AG's management efficiency ratios could be used to measure how well Paion AG manages its routine affairs as well as how well it operates its assets and liabilities.Paion AG owns a total of 71.34 Million outstanding shares. Paion AG holds 8.0 pct. of its outstanding shares held by insiders and 3.93 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Some institutional investors establish a significant position in pink sheets such as Paion AG in order to find ways to drive up its value. Retail investors, on the other hand, need to know that institutional holders can own millions of shares of Paion AG, and when they decide to sell, the pink sheet will often sell-off, which may instantly impact shareholders' value. So, traders who get in early or near the beginning of the institutional investor's buying cycle could potentially generate profits.
Paion AG Workforce Comparison
Paion AG is considered to be number one stock in number of employees category among its peers. The total workforce of Drug Manufacturers—Specialty & Generic industry is at this time estimated at about 291. Paion AG totals roughly 62.0 in number of employees claiming about 21% of equities under Drug Manufacturers—Specialty & Generic industry.
The company has Profit Margin (PM) of (0.09) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.11) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.11. Paion AG Notable Stakeholders
A Paion AG stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Paion AG often face trade-offs trying to please all of them. Paion AG's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Paion AG's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Ralf Penner | Director of Investor Relations and PR | Profile | |
| Thomas Stoehr | VP Devel | Profile | |
| Shaw Sorooshian | VP Affairs | Profile | |
| ChB MBA | CEO Board | Profile | |
| Sebastian Werner | Member CFO | Profile |
About Paion AG Management Performance
The success or failure of an entity such as Paion AG often depends on how effective the management is. Paion AG management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Paion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Paion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and critical care services worldwide. Paion AG was founded in 2000 and is based in Aachen, Germany. Paion Ag operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 64 people.
Paion AG Workforce Analysis
Traditionally, organizations such as Paion AG use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Paion AG within its industry.Paion AG Manpower Efficiency
Return on Paion AG Manpower
| Revenue Per Employee | 115K | |
| Revenue Per Executive | 1.4M | |
| Net Loss Per Employee | 351.4K | |
| Net Loss Per Executive | 4.4M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Paion Pink Sheet
If you are still planning to invest in Paion AG check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Paion AG's history and understand the potential risks before investing.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Transaction History View history of all your transactions and understand their impact on performance |